Xeris Biopharma Holdings, Inc. Common Stock (XERS) News

Latest headlines that mention XERS, newest first · each headline opens the original publisher

XERS quote

Last price: $10.31
Day change: +2.38%
Next earnings: 2026-11-05

Quote & chart Expected move Insider trading IV rank history

XERS headlines

last 30 days

Investing.com 4d ago

Xeris Biopharma CLO Beth Hecht sells $156,792 in XERS shares

General T3XERS

Investing.com 17d ago

Lundbeck approaches Xeris Biopharma over potential takeover, Bloomberg reports

M&A T3XERS

Reuters 17d ago

Lundbeck expresses interest in buying Xeris, Bloomberg News reports

General T1XERS

Seeking Alpha 17d ago

Xeris Biopharma jumps on report of interest from H Lundbeck

General T2XERS

Bloomberg Markets 17d ago

Lundbeck Is Said to Express Interest in Xeris Biopharma

H Lundbeck A/S has expressed interest in acquiring Xeris Biopharma Holdings Inc., a US drugmaker specialized in injectable medicines, people familiar with the matter said.

General T1XERS

Investing.com 17d ago

Xeris Biopharma stock hits 52-week high at 10.08 USD

General T3XERS

XERS news alerts

Get an alert by email or push when a new headline mentions XERS.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.